We sit down with you and build your perfect lead list. Book a call with founders.

OrganOx Analysis: $238M Raised

What is OrganOx?

Normothermic perfusion technology for liver transplantation
Location
Oxford, United Kingdom
Employees
201-500
Founded
2008

Product Features & Capabilities

  • metra® liver perfusion device
  • Product documentation for metra®
  • NMP technology for organ preservation

Other Considerations

Acquired by Terumo Corporation to advance organ transplantation; metra® received FDA approval for air transport; Collaborates with top institutions for organ research

Find more companies like OrganOx

VC-backed University Spinouts

Financial Overview

$238MTotal Raised
Series D
Want to research more data points on OrganOx?
Start with Extruct

Platform Links